BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 352634)

  • 1. The effect of lidoflazine on exercise tolerance in patients with angina pectoris.
    Nordstrom LA; Globel FL
    Chest; 1978 Jul; 74(1):50-4. PubMed ID: 352634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidoflazine and physical training in the treatment of stable angina pectoris.
    Ferguson RJ; Côté P; Bourassa MG; Corbara F
    Clin Cardiol; 1979 Dec; 2(6):413-6. PubMed ID: 397017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidoflazine in the management of angina pectoris.
    Bloem TJ; Vermeulen A; Reneman RS
    Clin Cardiol; 1979 Dec; 2(6):407-12. PubMed ID: 397016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled evaluation of lidoflazine in patients receiving beta-blocker therapy with propranolol: improvement in anginal symptoms and exercise tolerance with combined drug therapy.
    Strauss WE; Parisi AF
    Am J Cardiol; 1984 Apr; 53(8):1003-7. PubMed ID: 6422735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris.
    Shapiro W; Narahara KA; Park J
    Circulation; 1982 Jan; 65(1 Pt 2):I43-50. PubMed ID: 6796288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
    Lehmann H; Hochrein H
    Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved exercise myocardial perfusion during lidoflazine therapy.
    Shapiro W; Narahara KA; Park J
    Angiology; 1983 Nov; 34(11):705-10. PubMed ID: 6638605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angina pectoris: effects of lidoflazine on exercise tolerance and chest pain.
    Jenkins MD; Swallow EA; Abdel-Hadi O; Kidner PH
    Am J Cardiol; 1981 Jul; 48(1):140-6. PubMed ID: 7246436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfarction exercise capacity after lidoflazine treatment or physical training.
    Degré S; Lenaers A; Messin R; Vandermoten P; Salhadin P; Limage M; Denolin H
    Cardiology; 1979; 64(1):35-47. PubMed ID: 365332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind clinical and ECG-evaluation of lidoflazine (R 7904) in the treatment of stabilized angina pectoris.
    Keulen UW
    Curr Med Res Opin; 1973; 1(8):469-81. PubMed ID: 4589632
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification pitfalls in comparative studies of antianginal therapies.
    Tremblay G; Biron P; Proulx A
    Am Heart J; 1975 Apr; 89(4):521-5. PubMed ID: 803767
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lidoflazine as an anti-anginal drug.
    Vohra JK; Sloman JG
    Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial and detrimental effects of lidoflazine in microvascular angina.
    Cannon RO; Brush JE; Schenke WH; Tracy CM; Epstein SE
    Am J Cardiol; 1990 Jul; 66(1):37-41. PubMed ID: 2193496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of prolonged lidoflazine (R 7904) treatment on resting ECG, heart rate and blood pressure. A retrospective study.
    Bosmans P; Reinards J; Terrijn R; Vandervoort R
    Acta Cardiol; 1977; 32(2):87-97. PubMed ID: 302077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.
    Meilink-Hoedemaker LJ; Pool J; Muste-Heijns MM
    Acta Med Scand; 1976; 199(1-2):17-23. PubMed ID: 766572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris.
    Brantmark B; Egelius N; Fabricius E; Jemt M; Palmborg G; Philipson J; Rönnegård N
    Eur J Clin Pharmacol; 1973 Oct; 6(3):156-62. PubMed ID: 4202654
    [No Abstract]   [Full Text] [Related]  

  • 18. Lidoflazine and angina pectoris: a placebo-controlled double-blind study.
    Aravanis C; Counelis E; Ieremias D
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):285-90. PubMed ID: 4197252
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term evaluation of lidoflazine in angina pectoris based on exercise tolerance.
    Piessens J; De Geest H
    Cardiology; 1972; 57(3):135-49. PubMed ID: 4557527
    [No Abstract]   [Full Text] [Related]  

  • 20. [Non-invasive examination of cardiac hemodynamics in an anginal coronary syndrome after long term treatment with lidoflazine].
    Dvorák I; Zemánková J; Bravený P; Blaha M; Dvorák M; Sedá L; Havlát F
    Vnitr Lek; 1981 Apr; 27(4):338-44. PubMed ID: 7027603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.